CD4 and benign prostatic hyperplasia: Our rationale was that if a macrophage and neutrophil-based inflammation in the tumor microenvironment produces reactive oxygen and reactive nitrogen species, protective thioredoxin protein partners must be upregulated in order to maintain stromal cell viability, whereas this would be unnecessary in the CD4+ T-Lymphocyte-based inflammation seen in BPH.